Fed. Circ. Backs Sequenom Bid To Bar Ariosa Prenatal Test

Law360, New York (August 9, 2013, 4:48 PM EDT) -- The Federal Circuit on Friday gave Sequenom Inc. another chance to obtain a preliminary injunction on an Ariosa Diagnostics Inc. prenatal blood test it claims infringe its patent, finding that a lower court did not properly consider how Ariosa's test could harm Sequenom.

The appeals court vacated U.S. District Judge Susan Illston's July 2012 decision not to impose a preliminary injunction on Ariosa's Harmony test for genetic defects in a fetus, which competes with Sequenom's MaterniT21 test. 

The judge said she denied the injunction in part...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.